|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ma LW and Jia TZ: Optimal management for
hepatocellular carcinoma. China J Cancer Prev Treat. 12:471–473.
2005.
|
|
4
|
Kettenbach J, Stadler A, Katzler IV,
Schernthaner R, Blum M, Lammer J and Rand T: Drug-loaded
microspheres for the treatment of liver cancer: review of current
results. Cardiovasc Intervent Radiol. 31:468–476. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kanno S, Shouji A, Asou K and Ishikawa M:
Effects of naringin on hydrogen peroxide-induced cytotoxicity and
apoptosis in P388 cells. J Pharmacol Sci. 92:166–170. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Birt DF, Hendrich S and Wang W: Dietary
agents in cancer prevention: Flavonoids and isoflavonoids.
Pharmacol Ther. 90:157–177. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mendell JT: miRiad roles for the miR-17-92
cluster in development and disease. Cell. 133:217–222. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jung YJ, Kim JW, Park SJ, Min BY, Jang ES,
Kim NY, Jeong SH, Shin CM, Lee SH, Park YS, et al: c-Myc-mediated
overexpression of miR-17-92 suppresses replication of hepatitis B
virus in human hepatoma cells. J Med Virol. 85:969–978. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu M, Wang Z, Yang S, Zhang W, He S, Hu
C, Zhu H, Quan L, Bai J and Xu N: TNF-α is a novel target of
miR-19a. Int J Oncol. 38:1013–1022. 2011.PubMed/NCBI
|
|
11
|
Tang W, Zhu J, Su S, Wu W, Liu Q, Su F and
Yu F: MiR-27 as a prognostic marker for breast cancer progression
and patient survival. PLoS One. 7:e517022012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakagawa H, Umemura A, Taniguchi K,
Font-Burgada J, Dhar D, Ogata H, Zhong Z, Valasek MA, Seki E,
Hidalgo J, et al: ER stress cooperates with hypernutrition to
trigger TNF-dependent spontaneous HCC development. Cancer Cell.
26:331–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer. 96
Suppl:R40–R44. 2007.PubMed/NCBI
|
|
14
|
le Sage C and Agami R: Immense promises
for tiny molecules: Uncovering miRNA functions. Cell Cycle.
5:1415–1421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kusenda B, Mraz M, Mayer J and Pospisilova
S: MicroRNA biogenesis, functionality and cancer relevance. Biomed
Pap Med Fac Univ Palacky Olomouc Czech Repub. 150:205–215. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu SP, Sun GP, Shen YX, Wei W, Peng WR and
Wang H: Antiproliferation and apoptosis induction of paeonol in
HepG2 cells. World J Gastroenterol. 13:250–256. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
de la Peña F Ayala, Kanasaki K, Kanasaki
M, Tangirala N, Maeda G and Kalluri R: Loss of p53 and acquisition
of angiogenic microRNA profile are insufficient to facilitate
progression of bladder urothelial carcinoma in situ to invasive
carcinoma. J Biol Chem. 286:20778–20787. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reichek JL, Duan F, Smith LM, Gustafson
DM, Oconnor RS, Zhang C, Dunlevy MJ, Gastier-Foster JM and Barr FG:
Genomic and clinical analysis of amplification of the 13q31
chromosomal region in alveolar rhabdomyosarcoma: A report from the
Childrens Oncology Group. Clin Cancer Res. 17:1463–1473. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang YX, Lang F, Liu YX, Yang CQ and Gao
HJ: In situ hybridization analysis of the expression of miR-106b in
colonic cancer. Int J Clin Exp Pathol. 8:786–792. 2015.PubMed/NCBI
|
|
20
|
Tian L, Fang YX, Xue JL and Chen JZ: Four
microRNAs promote prostate cell proliferation with regulation of
PTEN and its downstream signals in vitro. PLoS One. 8:e758852013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu XM, Wang XB, Chen MM, Liu T, Li YX, Jia
WH, Liu M, Li X and Tang H: MicroRNA-19a and −19b regulate cervical
carcinoma cell proliferation and invasion by targeting CUL5. Cancer
Lett. 322:148–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Packham G and Cleveland JL: c-Myc and
apoptosis. Biochimica et Biophysica Acta. 1242:11–28.
1995.PubMed/NCBI
|
|
23
|
Brady HJ and Gil-Gómez G: Bax. The
pro-apoptotic Bcl-2 family member, Bax. Int J Biochem Cell Biol.
30:647–650. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu QL, Abel P, Foster CS and Lalani EN:
bcl-2: Role in epithelial differentiation and oncogenesis. Hum
Pathol. 27:102–110. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bae S, Lee EM, Cha HJ, Kim K, Yoon Y, Lee
H, Kim J, Kim YJ, Lee HG, Jeung HK, et al: Resveratrol alters
microRNA expression profiles in A549 human non-small cell lung
cancer cells. Mol Cells. 32:243–249. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Law PT and Wong N: Emerging roles of
microRNA in the intracellular signaling networks of hepatocellular
carcinoma. J Gastroenterol Hepatol. 26:437–449. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xi S, Dyer KF, Kimak M, Zhang Q, Gooding
WE, Chaillet JR, Chai RL, Ferrell RE, Zamboni B, Hunt J, et al:
Decreased STAT1 expression by promoter methylation in squamous cell
carcinogenesis. J Natl Cancer Inst. 98:181–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
